The global Cerebrospinal Fluid (CSF) Management market is expected to reach $XX billion by 2023 from $XX billion in 2017 growing at a CAGR of XX%. Cerebrospinal Fluid (CSF) is a clear, colorless fluid that flows in and around the hollow spaces of the brain and spinal cord, and between two of the meninges. It is made by choroid plexus tissue in the ventricles (hollow spaces) in the brain. Cerebrospinal fluid (CSF) disorders generally result in an excess volume of CSF within the neuraxis and an increase in intracranial pressure, defined as hydrocephalus. The market is expected to show a modest growth at a CAGR of XX%. The growth may be attributed to the rising incidences of the neurological diseases coupled with increasing cases of neonatal infections and neural tube defects across the globe. Rising geriatric population with higher susceptibility to neurological disorders such as Parkinson’s and Alzheimer’s disease will also boost the market growth for Cerebrospinal Fluid (CSF) Management during the given forecast period. However, lack of trained professionals coupled with the complications associated with CSF Shunts might restrain the growth of the CSF management market during the given time frame.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical region. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the global CSF management market value chain. Last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global CSF management market.
Major industry players profiled as part of the report are Thermo Fisher Scientific, Möller Medical GmbH and Medtronic among others.
Segmentation
By Type
Shunt
CSF Drainage Systems
By Age Group
Neonatal
Pediatric
Adult
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
India
Australia
South Korea
Others
Key questions answered by the report
What will be the global retractable safety syringes market size from 2018 to 2023?
How are the major drivers and restraints affecting the global retractable safety syringes market growth and the opportunities which exist for key vendors?
Which segment and region will drive or lead the market growth and why?
A comprehensive analysis of competitive landscape and key market participants’ behaviour
Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth